Chronic Inducible Urticaria (CIndU): Dermographism, Cold, And Cholinergic

Chronis Inducible Urticaria (CIndU): Dermographism Cold, And Cholinergic Trial

Trial ID: NCT05976243

Phase 3 | Oral tablet | 52 week treatment period | 4 week safety follow up

• ≥ 18 years old
• Diagnosed with Dermographism, Cold Urticaria, or Cholinergic Urticaria for ≥ 4 months
• Inadequate control of symptoms despite using H1-antihistamines (H1-AH)

Exclusion Criteria:

• Concomitant diagnosis of Chronic Spontaneous Urticaria (Hives)
• Received treatments using Remibrutinib or other BTK inhibitors
• A 4 month washout period is mandatory for participants who received treatment using other  biologics
• Using anticoagulant or anti-platelet medications, except for low doses of acetylsalicylic acid or clopidogrel